Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ZIDA Wearable Neuromodulation System

K-Number: K192731 · 2021-03-19

ApplicantExodus Innovations
Decision Date2021-03-19
Product CodeNAM
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

ZIDA Wearable Neuromodulation System is a medical device manufactured by Exodus Innovations. It received FDA 510(k) clearance on 2021-03-19 under approval number K192731. The device is classified under product code NAM. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ZIDA Wearable Neuromodulation System?

ZIDA Wearable Neuromodulation System is a medical device that received FDA 510(k) clearance on 2021-03-19. It is manufactured by Exodus Innovations. The 510(k) number is K192731.

When was ZIDA Wearable Neuromodulation System approved by the FDA?

ZIDA Wearable Neuromodulation System received FDA 510(k) clearance on 2021-03-19, under approval number K192731.

What company makes ZIDA Wearable Neuromodulation System?

ZIDA Wearable Neuromodulation System is manufactured by Exodus Innovations.

What is the FDA product code for ZIDA Wearable Neuromodulation System?

The FDA product code for ZIDA Wearable Neuromodulation System is NAM.

Related Clinical Trials

NCT07614581 Intra-Sessional Autonomic Arc Detection in Ketamine-Assisted Therapy for PTSD: A Signal Characterisation Pilot Study NOT_YET_RECRUITING NCT06385392 Continuous Wearable Monitor for the Detection and Release of Freezing of Gait. COMPLETED NCT07575750 Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA) NOT_YET_RECRUITING NCT07595848 Integration of Wearable Sensor Devices Into a Single System to Predict the Onset of Sepsis NOT_YET_RECRUITING NCT04786821 Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis COMPLETED NCT07193407 INOPASE - Performance and Safety Study of a Personalised SNM System RECRUITING

Related Devices (Code: NAM)

K220454Vivally System Wearable, Non-Invasive Neuromodulation System and Mobile ApplicationAvation Medical, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑